1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Bionovate Technologies Corp

Bionovate Technologies Corp

BIIO
Bionovate Technologies CorpUS flagOther OTC
0.00
USD
- -
- -
775.00Market Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
TTM
Revenue per Share
10.18
2.56
1.38
1.9
1.81
- -
- -
- -
- -
- -
Basic EPS, GAAP
-30.9
-28.32
-14.97
-11.91
-108.49
-27.46
-1.34
- -
- -
- -
Free Cash Flow per Basic Share
-22.65
-17.5
-0.1
0.13
3.56
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-35.56
-59.6
-74.56
-86.96
-210.25
-37.31
-16.54
-0.11
-0.06
-0.08
Tangible Book Value per Share
3.05
-25.74
-36.11
-46.77
-76.9
-4.88
-2.13
-0.02
-0.01
-0.01
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
25
45
37
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-303.48
-1,105.65
-1,086.9
-627.02
-1,628.93
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
-2
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-303.48
-1,105.65
-1,086.9
-627.02
-6,002.84
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'21
Jun'21
Sep'22
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
46
8
8
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'21
Jun'21
Sep'22
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
1
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
28.16%
26.86%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
207.79%
-12.7%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
-0.19
-0.29
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Timothy Jones
Sector
Healthcare
Industry
Medical - Devices
Address
Gewerbestrasse 10 Cham ZG Switzerland 6330
IPO Date
Jun 12, 2014
CIK
0001575420
Website
bionovate.com
Similar Companies
Medinice S.A. (ICE.WA)
Business Alignment Public Company Limited (BIZ.BK)
SomnoMed Limited (SOM.AX)
IR-Med Inc. (IRME)
Endymed Ltd (ENDY.TA)
Stryker Corporation (SYK.DE)
Business
Bionovate Technologies Corp (BIIO) is a medical device company focused on developing automated computerized treatment systems for age spots, or solar lentigines, utilizing a scan-and-treat protocol that precisely removes spots without affecting surrounding skin; the company targets sales of these systems to physicians, spas, and healthcare providers worldwide. Founded in 2010 and headquartered in Cham, Switzerland, at Gewerbestrasse 10, it operates in the healthcare equipment sector with no reported revenue and ongoing losses as of the latest filings. Formerly known as MJP International Ltd., the company changed its name in December 2017 and became a subsidiary of Human Data AG following the parent's acquisition of a 91.3% stake from Evergreen Solutions Ltd in October 2020 via a share exchange agreement involving Digital Diagnostics AG shares; no significant updates, product launches, funding rounds, or operational expansions have been reported in the last 1-2 years, with the firm maintaining a minimal market capitalization and inactive trading status on OTC Markets.

Company News

APIChatGPT